Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 23;14(2):132.
doi: 10.3390/jpm14020132.

Prevention in Hepatology

Affiliations
Review

Prevention in Hepatology

Ana-Maria Muñoz-Restrepo et al. J Pers Med. .

Abstract

The prevention of liver disease has improved significantly in the last few decades, to the point that it can now be considered a true success story. The wide variety of interventions, including comprehensive vaccination strategies, novel medications, lifestyle changes, and even preventive surgeries, have reduced the morbidity and mortality of chronic liver diseases. However, the prevalence of chronic liver diseases is increasing worldwide. Currently, fatty liver disease alone is estimated to be present in as much as 30% of the adult population. Furthermore, there is a trend towards increasing incidences of chronic hepatitis B, and a global lack of success in efforts to eliminate chronic hepatitis C. Thus, improving and efficiently rolling out existing and successful prevention strategies for chronic liver diseases will play an essential role in healthcare throughout the upcoming decades. In this review, we summarize the current options and concepts for preventing chronic liver diseases, highlight their limitations, and provide an outlook on probable future developments to improve awareness, integrated care, and the analysis of big data.

Keywords: hepatology; liver disease; management; prevention.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Asrani S.K., Devarbhavi H., Eaton J., Kamath P.S. Burden of liver diseases in the world. J. Hepatol. 2019;70:151–171. doi: 10.1016/j.jhep.2018.09.014. - DOI - PubMed
    1. Ginès P., Krag A., Abraldes J.G., Solà E., Fabrellas N., Kamath P.S. Liver cirrhosis. Lancet. 2021;398:1359–1376. doi: 10.1016/S0140-6736(21)01374-X. - DOI - PubMed
    1. GBD 2019 Diseases and Injuries Collaborators Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204–1222. doi: 10.1016/S0140-6736(20)30925-9. - DOI - PMC - PubMed
    1. Kaplan D.E., Chapko M.K., Mehta R., Dai F., Skanderson M., Aytaman A., Baytarian M., D’Addeo K., Fox R., Hunt K., et al. Healthcare Costs Related to Treatment of Hepatocellular Carcinoma among Veterans with Cirrhosis in the United States. Clin. Gastroenterol. Hepatol. 2018;16:106–114.e5. doi: 10.1016/j.cgh.2017.07.024. - DOI - PMC - PubMed
    1. Marcellin P., Kutala B.K. Liver diseases: A major, neglected global public health problem requiring urgent actions and large-scale screening. Liver Int. 2018;38:2–6. doi: 10.1111/liv.13682. - DOI - PubMed

LinkOut - more resources